Debu Tripathy, MD
Professor of Medicine & Chair, Breast Medical Oncology, University of Texas MD Anderson Cancer Center
Highlights
- LBBC Medical Advisory Board member since 2023
- Speaker, 2024 Conference on Metastatic Breast Cancer and 2022 Virtual Conference on Metastatic Breast Cancer
Debu Tripathy, MD, is a professor of medicine and chair of the Department of Breast Medical Oncology at the University of Texas MD Anderson Cancer Center. He earned a degree in chemical engineering from the Massachusetts Institute of Technology and completed medical school and an internal medicine residency at Duke University, followed by a Hematology/Oncology fellowship at the University of California, San Francisco.
His clinical research focuses on evaluating and developing novel therapeutics in breast cancer, specifically those targeting sensitivity and resistance mechanisms to growth factors, endocrine modulators, and cell cycle control pathways. He also investigates biomarkers predicting sensitivity and resistance. Dr. Tripathy has led clinical trials supporting the approval of new biological therapies for breast cancer targeting the HER2 oncogene and cyclin-dependent kinases, both improving patient survival.
Dr. Tripathy has published numerous original translational and landmark clinical research articles in the field of breast cancer. He serves on several editorial boards, study sections, and societies, and he is the editor-in-chief of CURE Magazine. He has previously served as president of the American Society of Breast Disease and of the Society of Integrative Oncology.
